September 19, 2024 article from the Journal of Orthomolecular Medicine.

Focusing on the mitochondrial-stem cell connection (MSCC,) the authors propose a protocol using vitamins, drugs, and dietary changes to target this process, aiming to disrupt cancer’s energy sources and stem cells.

“Drawing on insights from molecular biology, pharmacology, and clinical studies, this manuscript introduces a hybrid orthomolecular protocol targeting the MSCC. The protocol includes 7 therapeutic recommendations, consisting of orthomolecules, drugs, and additional therapies. The aim of this hybrid orthomolecular protocol is to achieve additive and synergistic effects to enhance OxPhos, inhibit the primary fuels of cancer cells (glucose and glutamine), target CSCs and metastasis.”